SCHEMBL30618088

SCHEMBL30618088

COc1ccc(C(OC[C@]2(CO[Si](C)(C)C(C)(C)C)O[C@H](c3ncc(F)cn3)[C@H](F)[C@@H]2O[Si](C)(C)C(C)(C)C)(c2ccccc2)c2ccc(OC)cc2)cc1

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ SLC6A1 P30531 2/20 0.30
▸ SLC6A11 P48066 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30618137 0.93 SLC6A1 (0.30) SLC6A1SLC6A11
SCHEMBL30618100 0.93 SLC6A1 (0.31) SLC6A1SLC6A11
SCHEMBL16701345 0.77 EGFR (0.34) —
SCHEMBL25399442 0.76 HSP90AA1 (0.40) —
SCHEMBL31572670 0.76 TYMP (0.33) —
SCHEMBL21837314 0.76 ADORA3 (0.34) —
SCHEMBL25397674 0.76 DUT (0.38) —
SCHEMBL31678879 0.74 — —
SCHEMBL12769530 0.72 — —
SCHEMBL17453463 0.71 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4493573-A1 COMPOUNDS AND METHODS FOR TREATING DISEASE Rome Therapeutics, Inc. (US) 2025-01-22 — — EP disclosed
WO-2023178133-A1 COMPOUNDS AND METHODS FOR TREATING DISEASE ROME THERAPEUTICS, INC. (US) 2023-09-21 — — WO disclosed
Send feedback